A group led by the Department of Neurosurgery at the Brain Research Institute, Niigata University, has successfully diagnosed ...

Leadoptik today announced the successful first-in-human clinical use of its FDA-cleared Last Inch Assessment (LIA) system.

@hopkinskimmel researchers develop novel liquid biopsy approach to identifying early-stage cancers. › ...

The fear that a biopsy can spread cancer continues to delay diagnosis and treatment. Oncologists explain why biopsy is safe, ...

Research from NeuroQure, a biotechnology company specializing in autism spectrum disorder, has led to the development of a ...

Robotic-assisted transperineal fusion biopsy led to relatively low rates of prostate cancer upgrading and downgrading in a ...

By determining the structure of the deposits responsible for transthyretin amyloidosis through a simple skin biopsy, ...

Diagnostic tools based on artificial intelligence are now making their way into Norwegian hospitals. AI can independently read X-ray images and detect bone fractures, or assess cancer tumors in both ...

Olympus today announced the U.S. launch of its most advanced single-use fine needle biopsy device used in ultrasound-guided ...

For prostate biopsy planning, multiparametric MRI has relatively low specificity particularly for PI-RADS 3 and PI-RADS 4 lesions. Dual imaging might help.

Twist Bioscience's Q1 growth was modest, due in large part to an air pocket in demand caused by a large NGS customer. Read ...

The global liquid biopsy market is experiencing substantial growth, driven by increasing demand for non-invasive diagnostic technologies that detect molecular biomarkers using liquid samples, thus ...